Nirsevimab significantly protected infants against RSV disease in Phase 3 trial

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

China ,Japan ,Tokyo ,United States ,Paris ,France General ,France ,United Kingdom ,Philadelphia ,Pennsylvania ,Langley ,Northumberland ,California ,Illinois ,Chicago ,Eva Schaefer Jansen ,Nicolas Obrist ,Corentine Driancourt ,William Muller ,Felix Lauscher ,Kate Conway ,Ann Roberth Lurie ,Nathalie Pham ,Sandrine Guendoul ,Sally Bain ,Priya Nanduri ,Nasdaq ,Northwestern University Feinberg School Of Medicine ,Global Head Of Research ,Astrazeneca ,California Perinatal Association ,Burden Of Community ,Japan Agency For Medical Research ,Oxford Vaccines Group ,China Center ,Health Alert Network ,Centers For Disease ,Drug Administration ,Community Trials ,Regulatory Agency ,European Medicines Agency Prioritymedicinesscheme ,National Medical Products Administration ,Development Vaccines ,Euronext ,Thenew England Journal ,New England Journal ,Northwestern University Feinberg School ,Scientific Director ,Vice President ,Southern Hemispheres ,Collaboration Revenue ,Breakthrough Therapy Designation ,Drug Evaluation ,European Medicines Agency ,Promising Innovative Medicine ,United Kingdom Medicines ,Drug Selection ,Promote New Drug Development ,Japan Agency ,Medical Research ,Private Securities Litigation Reform Act ,Statement Regarding Forward Looking ,Healthy Late ,Term Infants ,Medically Attended ,Healthy Late Preterm ,Healthy Preterm ,Single Dose Nirsevimab ,Preterm Infants ,Lung Diseaseor ,Medically Attended Respiratory Syncytial Virus ,Lower Respiratorytrackinfection ,Syncytial Virus ,California Perinatal ,Oxford Vaccines ,Respiratory Syncytial Virus Infections ,Increasedinterseasonalrespiratory Syncytial Virus ,Southern United ,Disease Control ,Associated Hospitalizations Among Young Children ,Intensive Care Units ,Retrospectively Matched Cohort Study ,Infection Control ,Coronavirus Pandemic ,Science ,Business ,Health ,Globe Newswire ,Immunizations ,